(Q43451421)

English

Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro

scientific article published on 24 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

cholangiocarcinoma

0 references

1 reference

based on heuristic

inferred from title

author name string

Xiang Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Yanfen Zou

2

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Quan Li

3

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Yonghuan Mao

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Hui Zhu

5

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Guangming Huang

6

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Guozhong Ji

7

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Xiagang Luo

8

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Chunzhao Yu

9

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Xiuhua Zhang

10

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

publication date

24 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

3103-3112

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

https://scigraph.springernature.com/pub.10.1007/s13277-013-1402-y

0 references

A review and update on cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Cholangiocarcinoma: lessons from Thailand

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Recent advances in the management of cholangiocarcinomas

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Radical surgery: vascular and pancreatic resection for cholangiocarcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Cholangiocarcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Decorin is a biological ligand for the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

The role of decorin in collagen fibrillogenesis and skin homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Decorin-mediated inhibition of colorectal cancer growth and migration is associated with E-cadherin in vitro and in mice

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Identification of genes down-regulated during lung cancer progression: a cDNA array study

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

An antimetastatic role for decorin in breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Small proteoglycans

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Decorin evokes protracted internalization and degradation of the epidermal growth factor receptor via caveolar endocytosis

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Decorin, a novel player in the insulin-like growth factor system.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Binding of von Willebrand factor to the small proteoglycan decorin

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Convergence of Wnt, beta-catenin, and cadherin pathways

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Cadherins as Modulators of Cellular Phenotype

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Solubility of Collagen Fibrils formed in vitro in the Presence of Sulphated Acid Mucopolysaccharide-protein

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1402-Y

21 January 2018

Recombinant human decorin upregulates p57KIP² expression in HepG2 hepatoma cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decorin-induced Growth Suppression Is Associated with Up-regulation of p21, an Inhibitor of Cyclin-dependent Kinases

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein A, avidin, and biotin in immunohistochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Forced expression of E-cadherin in the mouse intestinal epithelium slows cell migration and provides evidence for nonautonomous regulation of cell fate in a self-renewing system

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24272200

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13277-013-1402-Y

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43451421&oldid=2165252788"